Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Multiple Myeloma × darinaparsin × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 129 Lenalidomide 56 Bortezomib 54 Calcium Dobesilate 43 Melphalan 41 carfilzomib 38 Cyclophosphamide 35 pomalidomide 34 daratumumab 23 belantamab mafodotin 20 Peripheral Blood Stem Cell Transplantation 17 ixazomib 16 dexamethasone acetate 13 Filgrastim 13 Bendamustine Hydrochloride 13 fludarabine phosphate 12 fludarabine 12 dexamethasone 21-phosphate 12 Tacrolimus 12 auricularum 11 Whole-Body Irradiation 11 liposomal doxorubicin 10 Prednisone 10 venetoclax 9 selinexor 9 iberdomide 9 Mycophenolic Acid 9 pembrolizumab 8 Cyclosporine 8 Sirolimus 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00303199 2012-07-19

Study of ZIO-101 in Multiple Myeloma

Alaunos Therapeutics

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡